FDA Inspection
VitalantVitalant – FDA Inspection, Jun 27, 2024
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on June 27, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 6fc09fbd-6d45-4196-9c07-ba0a626ea5e6
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1242507
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 15, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 15, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 6, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 15, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 13, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1090371 - 2019-05-15
- FDA Inspection 1021901 - 2017-08-15
- FDA Inspection 918326 - 2015-03-06
- FDA Inspection 844627 - 2013-08-15
- FDA Inspection 749564 - 2011-10-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.